Bacteriophage Therapy Market 2027 By Targeted Bacteria, Route of Administration, Application, End User, and Geography | The Insight Partners

Bacteriophage Therapy Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Targeted Bacteria (Escherichia coli, Streptococcus, Pseudomonas, Staphylococcus, Salmonella, Others); Route of Administration (Oral, Topical, Parenteral); Application (Diagnostic, Antimicrobial Drug Discovery, Veterinary Medicines, Others); End User (Hospitals & Clinics, Academic Research Organizations & Institutes, Others), and Geography

Report Code: TIPRE00012613 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Bacteriophage therapy is also known as phage therapy. It needs viruses for the medication of bacterial infections. Bacterial viruses are called bacteriophages or phages. They combat bacteria; phages are safe to animals, plants, and humans. Bacteriophages are supposed to be natural antagonists of bacteria. Bacteriophages are found in soil, water, sewage, and other places where bacteria are exposed. Phage therapy is widely being reviewed as an option for antibiotics. Therefore, phage therapy is the remedial use of lytic bacteriophages for managing pathogenic bacterial infections.

MARKET DYNAMICS

The bacteriophage therapy market is driving due to the rising prevalence of drug-resistant infections, increasing research, and the development of products. However, the high cost of bacteriophage therapy and the shortage of skilled professionals are expected to hamper the growth of the global bacteriophage therapy market. Moreover, growing strategic alliances by market players are anticipated to drive demand for the growth of the market for bacteriophage therapy.

MARKET SCOPE

The "Bacteriophage Therapy Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of bacteriophage therapy market with detailed market segmentation by targeted bacteria, route of administration, application and end user. The bacteriophage therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in bacteriophage therapy market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The bacteriophage therapy market is segmented on the basis of targeted bacteria, route of administration, application and end user. Based on targeted bacteria, the market is segmented as Escherichia coli, Streptococcus, Pseudomonas, Staphylococcus, Salmonella, others. On the basis of route of administration, the market is categorized as oral, topical, parenteral. On the basis of application, the market is categorized as diagnostic, antimicrobial drug discovery, veterinary medicines, and others. On the basis of end user, the market is categorized as hospitals & clinics, academic research organizations & institutes, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the bacteriophage therapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bacteriophage therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting bacteriophage therapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the bacteriophage therapy market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the bacteriophage therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from bacteriophage therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for bacteriophage therapy in the global market. Below mentioned is the list of few companies engaged in the bacteriophage therapy market.

The report also includes the profiles of key players in bacteriophage therapy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Armata Pharmaceuticals, Inc.
  •  Intralytix, Inc.
  •  Pherecydes Pharma
  •  Eliava Bio Preparations LTD
  •  NEXTBIOTICS
  •  LOCUS BIOSCIENCES, INC.
  •  Fixed-Phage Limited
  •  Phage International, Inc.
  •  iNtODEWORLD, Inc.
  •  InnoPhage, Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS


1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bacteriophage Therapy Market - By Targeted Bacteria
1.3.2 Bacteriophage Therapy Market - By Route of Administration
1.3.3 Bacteriophage Therapy Market - By Application
1.3.4 Bacteriophage Therapy Market - By End User
1.3.5 Bacteriophage Therapy Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BACTERIOPHAGE THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BACTERIOPHAGE THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BACTERIOPHAGE THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. BACTERIOPHAGE THERAPY - GLOBAL MARKET OVERVIEW
6.2. BACTERIOPHAGE THERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BACTERIOPHAGE THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - TARGETED BACTERIA
7.1. OVERVIEW
7.2. TARGETED BACTERIA MARKET FORECASTS AND ANALYSIS
7.3. ESCHERICHIA COLI
7.3.1. Overview
7.3.2. Escherichia coli Market Forecast and Analysis
7.4. STREPTOCOCCUS
7.4.1. Overview
7.4.2. Streptococcus Market Forecast and Analysis
7.5. PSEUDOMONAS
7.5.1. Overview
7.5.2. Pseudomonas Market Forecast and Analysis
7.6. STAPHYLOCOCCUS
7.6.1. Overview
7.6.2. Staphylococcus Market Forecast and Analysis
7.7. SALMONELLA
7.7.1. Overview
7.7.2. Salmonella Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. BACTERIOPHAGE THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. TOPICAL
8.4.1. Overview
8.4.2. Topical Market Forecast and Analysis
8.5. PARENTERAL
8.5.1. Overview
8.5.2. Parenteral Market Forecast and Analysis
9. BACTERIOPHAGE THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTIC
9.3.1. Overview
9.3.2. Diagnostic Market Forecast and Analysis
9.4. ANTIMICROBIAL DRUG DISCOVERY
9.4.1. Overview
9.4.2. Antimicrobial Drug Discovery Market Forecast and Analysis
9.5. VETERINARY MEDICINES
9.5.1. Overview
9.5.2. Veterinary Medicines Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. BACTERIOPHAGE THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS & CLINICS
10.3.1. Overview
10.3.2. Hospitals & Clinics Market Forecast and Analysis
10.4. ACADEMIC RESEARCH ORGANIZATIONS & INSTITUTES
10.4.1. Overview
10.4.2. Academic Research Organizations & Institutes Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. BACTERIOPHAGE THERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Bacteriophage Therapy Market Overview
11.1.2 North America Bacteriophage Therapy Market Forecasts and Analysis
11.1.3 North America Bacteriophage Therapy Market Forecasts and Analysis - By Targeted Bacteria
11.1.4 North America Bacteriophage Therapy Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Bacteriophage Therapy Market Forecasts and Analysis - By Application
11.1.6 North America Bacteriophage Therapy Market Forecasts and Analysis - By End User
11.1.7 North America Bacteriophage Therapy Market Forecasts and Analysis - By Countries
11.1.7.1 United States Bacteriophage Therapy Market
11.1.7.1.1 United States Bacteriophage Therapy Market by Targeted Bacteria
11.1.7.1.2 United States Bacteriophage Therapy Market by Route of Administration
11.1.7.1.3 United States Bacteriophage Therapy Market by Application
11.1.7.1.4 United States Bacteriophage Therapy Market by End User
11.1.7.2 Canada Bacteriophage Therapy Market
11.1.7.2.1 Canada Bacteriophage Therapy Market by Targeted Bacteria
11.1.7.2.2 Canada Bacteriophage Therapy Market by Route of Administration
11.1.7.2.3 Canada Bacteriophage Therapy Market by Application
11.1.7.2.4 Canada Bacteriophage Therapy Market by End User
11.1.7.3 Mexico Bacteriophage Therapy Market
11.1.7.3.1 Mexico Bacteriophage Therapy Market by Targeted Bacteria
11.1.7.3.2 Mexico Bacteriophage Therapy Market by Route of Administration
11.1.7.3.3 Mexico Bacteriophage Therapy Market by Application
11.1.7.3.4 Mexico Bacteriophage Therapy Market by End User
11.2. EUROPE
11.2.1 Europe Bacteriophage Therapy Market Overview
11.2.2 Europe Bacteriophage Therapy Market Forecasts and Analysis
11.2.3 Europe Bacteriophage Therapy Market Forecasts and Analysis - By Targeted Bacteria
11.2.4 Europe Bacteriophage Therapy Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Bacteriophage Therapy Market Forecasts and Analysis - By Application
11.2.6 Europe Bacteriophage Therapy Market Forecasts and Analysis - By End User
11.2.7 Europe Bacteriophage Therapy Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Bacteriophage Therapy Market
11.2.7.1.1 Germany Bacteriophage Therapy Market by Targeted Bacteria
11.2.7.1.2 Germany Bacteriophage Therapy Market by Route of Administration
11.2.7.1.3 Germany Bacteriophage Therapy Market by Application
11.2.7.1.4 Germany Bacteriophage Therapy Market by End User
11.2.7.2 France Bacteriophage Therapy Market
11.2.7.2.1 France Bacteriophage Therapy Market by Targeted Bacteria
11.2.7.2.2 France Bacteriophage Therapy Market by Route of Administration
11.2.7.2.3 France Bacteriophage Therapy Market by Application
11.2.7.2.4 France Bacteriophage Therapy Market by End User
11.2.7.3 Italy Bacteriophage Therapy Market
11.2.7.3.1 Italy Bacteriophage Therapy Market by Targeted Bacteria
11.2.7.3.2 Italy Bacteriophage Therapy Market by Route of Administration
11.2.7.3.3 Italy Bacteriophage Therapy Market by Application
11.2.7.3.4 Italy Bacteriophage Therapy Market by End User
11.2.7.4 Spain Bacteriophage Therapy Market
11.2.7.4.1 Spain Bacteriophage Therapy Market by Targeted Bacteria
11.2.7.4.2 Spain Bacteriophage Therapy Market by Route of Administration
11.2.7.4.3 Spain Bacteriophage Therapy Market by Application
11.2.7.4.4 Spain Bacteriophage Therapy Market by End User
11.2.7.5 United Kingdom Bacteriophage Therapy Market
11.2.7.5.1 United Kingdom Bacteriophage Therapy Market by Targeted Bacteria
11.2.7.5.2 United Kingdom Bacteriophage Therapy Market by Route of Administration
11.2.7.5.3 United Kingdom Bacteriophage Therapy Market by Application
11.2.7.5.4 United Kingdom Bacteriophage Therapy Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Bacteriophage Therapy Market Overview
11.3.2 Asia-Pacific Bacteriophage Therapy Market Forecasts and Analysis
11.3.3 Asia-Pacific Bacteriophage Therapy Market Forecasts and Analysis - By Targeted Bacteria
11.3.4 Asia-Pacific Bacteriophage Therapy Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Bacteriophage Therapy Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Bacteriophage Therapy Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Bacteriophage Therapy Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Bacteriophage Therapy Market
11.3.7.1.1 Australia Bacteriophage Therapy Market by Targeted Bacteria
11.3.7.1.2 Australia Bacteriophage Therapy Market by Route of Administration
11.3.7.1.3 Australia Bacteriophage Therapy Market by Application
11.3.7.1.4 Australia Bacteriophage Therapy Market by End User
11.3.7.2 China Bacteriophage Therapy Market
11.3.7.2.1 China Bacteriophage Therapy Market by Targeted Bacteria
11.3.7.2.2 China Bacteriophage Therapy Market by Route of Administration
11.3.7.2.3 China Bacteriophage Therapy Market by Application
11.3.7.2.4 China Bacteriophage Therapy Market by End User
11.3.7.3 India Bacteriophage Therapy Market
11.3.7.3.1 India Bacteriophage Therapy Market by Targeted Bacteria
11.3.7.3.2 India Bacteriophage Therapy Market by Route of Administration
11.3.7.3.3 India Bacteriophage Therapy Market by Application
11.3.7.3.4 India Bacteriophage Therapy Market by End User
11.3.7.4 Japan Bacteriophage Therapy Market
11.3.7.4.1 Japan Bacteriophage Therapy Market by Targeted Bacteria
11.3.7.4.2 Japan Bacteriophage Therapy Market by Route of Administration
11.3.7.4.3 Japan Bacteriophage Therapy Market by Application
11.3.7.4.4 Japan Bacteriophage Therapy Market by End User
11.3.7.5 South Korea Bacteriophage Therapy Market
11.3.7.5.1 South Korea Bacteriophage Therapy Market by Targeted Bacteria
11.3.7.5.2 South Korea Bacteriophage Therapy Market by Route of Administration
11.3.7.5.3 South Korea Bacteriophage Therapy Market by Application
11.3.7.5.4 South Korea Bacteriophage Therapy Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Bacteriophage Therapy Market Overview
11.4.2 Middle East and Africa Bacteriophage Therapy Market Forecasts and Analysis
11.4.3 Middle East and Africa Bacteriophage Therapy Market Forecasts and Analysis - By Targeted Bacteria
11.4.4 Middle East and Africa Bacteriophage Therapy Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Bacteriophage Therapy Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Bacteriophage Therapy Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Bacteriophage Therapy Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Bacteriophage Therapy Market
11.4.7.1.1 South Africa Bacteriophage Therapy Market by Targeted Bacteria
11.4.7.1.2 South Africa Bacteriophage Therapy Market by Route of Administration
11.4.7.1.3 South Africa Bacteriophage Therapy Market by Application
11.4.7.1.4 South Africa Bacteriophage Therapy Market by End User
11.4.7.2 Saudi Arabia Bacteriophage Therapy Market
11.4.7.2.1 Saudi Arabia Bacteriophage Therapy Market by Targeted Bacteria
11.4.7.2.2 Saudi Arabia Bacteriophage Therapy Market by Route of Administration
11.4.7.2.3 Saudi Arabia Bacteriophage Therapy Market by Application
11.4.7.2.4 Saudi Arabia Bacteriophage Therapy Market by End User
11.4.7.3 U.A.E Bacteriophage Therapy Market
11.4.7.3.1 U.A.E Bacteriophage Therapy Market by Targeted Bacteria
11.4.7.3.2 U.A.E Bacteriophage Therapy Market by Route of Administration
11.4.7.3.3 U.A.E Bacteriophage Therapy Market by Application
11.4.7.3.4 U.A.E Bacteriophage Therapy Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Bacteriophage Therapy Market Overview
11.5.2 South and Central America Bacteriophage Therapy Market Forecasts and Analysis
11.5.3 South and Central America Bacteriophage Therapy Market Forecasts and Analysis - By Targeted Bacteria
11.5.4 South and Central America Bacteriophage Therapy Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Bacteriophage Therapy Market Forecasts and Analysis - By Application
11.5.6 South and Central America Bacteriophage Therapy Market Forecasts and Analysis - By End User
11.5.7 South and Central America Bacteriophage Therapy Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Bacteriophage Therapy Market
11.5.7.1.1 Brazil Bacteriophage Therapy Market by Targeted Bacteria
11.5.7.1.2 Brazil Bacteriophage Therapy Market by Route of Administration
11.5.7.1.3 Brazil Bacteriophage Therapy Market by Application
11.5.7.1.4 Brazil Bacteriophage Therapy Market by End User
11.5.7.2 Argentina Bacteriophage Therapy Market
11.5.7.2.1 Argentina Bacteriophage Therapy Market by Targeted Bacteria
11.5.7.2.2 Argentina Bacteriophage Therapy Market by Route of Administration
11.5.7.2.3 Argentina Bacteriophage Therapy Market by Application
11.5.7.2.4 Argentina Bacteriophage Therapy Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BACTERIOPHAGE THERAPY MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Rest of the World
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. BACTERIOPHAGE THERAPY MARKET, KEY COMPANY PROFILES
14.1. ARMATA PHARMACEUTICALS, INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. INTRALYTIX, INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. PHERECYDES PHARMA
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ELIAVA BIO PREPARATIONS LTD
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. NEXTBIOTICS
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. LOCUS BIOSCIENCES, INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. FIXED-PHAGE LIMITED
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. PHAGE INTERNATIONAL, INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. INTODEWORLD, INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. INNOPHAGE, LTD
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Armata Pharmaceuticals, Inc.
2. Intralytix, Inc.
3. Pherecydes Pharma
4. Eliava Bio Preparations LTD
5. NEXTBIOTICS
6. LOCUS BIOSCIENCES, INC.
7. Fixed-Phage Limited
8. Phage International, Inc.
9. iNtODEWORLD, Inc.
10. InnoPhage, Ltd
TIPRE00012613
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking